21st.BIO raised €86M in a funding round in Dec 2021. The company is based in Copenhagen, Denmark. Investors in the round: Novo Holdings. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €86M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
